Oral Contraceptives
Barr's Portia Generic Oral Contraceptive Approved and Launched in Canada
Published in Medical Letter on the CDC and FDA, September 16th, 2007
Barr Pharmaceuticals, Inc. (NYSE:BRL) announced that its subsidiary, Barr Laboratories, Inc., has received approval from the Therapeutic Products Directorate (TPD) of Health Canada for its Abbreviated New Drug Submission (ANDS) for its Portia(R) generic oral contraceptive as a generic equivalent of Wyeth Laboratories' Min-Ovral(R) Tablets. This represents the first approval of a generic oral contraceptive for Canadian consumers.
Under the terms of an agreement with Apotex, Inc., Barr will manufacture the product and Apotex will market it in Canada. Apotex will record the Canadian sales of Portia and will pay Barr a royalty from those sales.
"This...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Biological Warfare
Discovery may help defang viruses - Gene Therapy
Gamma globulin effective in treating eye infections caused by adenoviruses - HIV/AIDS
High-risk behaviors could lead to HIV epidemic in Afghanistan - Obesity
Professor Looks To Gardening To Combat Child Obesity - Virology
Expert On Emerging Infectious Zoonotic Diseases Joining K-State As A Regents Distinguished Professor - Acromegaly
Somatuline Depot Receives FDA Marketing Approval for the Treatment of Acromegaly - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
